IPO registrations (S-1, F-1) · Registrants
Lucid Diagnostics Inc.
- SEC CIK
- 1799011 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2021-09-22, last 2022-07-14; 2 initial registrations, 4 amendments
- Outcome
- Final prospectus filed 2021-10-15; declared effective 2021-10-13
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 360 MADISON AVENUE, 25TH FLOOR, New York, NY 10017
- EIN
- 82-5488042
- Ticker
- LUCD (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Lucid Diagnostics Inc. on the corporate pages
Offering terms
- Final price
- $14.00 per share (424B4 filed 2021-10-15, an initial public offering)
- Shares sold
- 5,000,000
- Gross proceeds
- $70,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol LUCD
- Lead underwriters
- Cantor Fitzgerald; BTIG; Needham & Company; of Contents
- Syndicate
- Canaccord Genuity
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: LUCID DIAGNOSTICS INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Lucid Diagnostics Inc Fuzzy (name and state)
- Business registration: Lucid Diagnostics Inc. Fuzzy (name and state)
- Business registration: LUCID DIAGNOSTICS INC. Fuzzy (name and state)
- Form D issuer: Lucid Diagnostics Inc. EXACT (CIK (EXACT))
- SEC filer: Lucid Diagnostics Inc. EXACT (CIK (EXACT))
- Person page: Dennis M Mcgrath Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
Filings 11
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-09-22 | S-1 | S-1 (registration) | Lucid Diagnostics Inc. | 0001493152-21-023367 ↗ |
| 2021-10-01 | S-1/A | S-1/A (amendment) | Lucid Diagnostics Inc. | 0001493152-21-024385 ↗ |
| 2021-10-07 | S-1/A | S-1/A (amendment) | Lucid Diagnostics Inc. | 0001493152-21-024865 ↗ |
| 2021-10-08 | S-1/A | S-1/A (amendment) | Lucid Diagnostics Inc. | 0001493152-21-025058 ↗ |
| 2021-10-13 | EFFECT | EFFECT (declared effective) | Lucid Diagnostics Inc. | 9999999995-21-003870 ↗ |
| 2021-10-15 | 424B4 | 424B4 (final prospectus) | Lucid Diagnostics Inc. | 0001493152-21-025472 ↗ |
| 2022-06-17 | S-1 | S-1 (registration) | Lucid Diagnostics Inc. | 0001493152-22-017026 ↗ |
| 2022-07-14 | S-1/A | S-1/A (amendment) | Lucid Diagnostics Inc. | 0001493152-22-019227 ↗ |
| 2022-07-22 | EFFECT | EFFECT (declared effective) | Lucid Diagnostics Inc. | 9999999995-22-002143 ↗ |
| 2022-12-06 | EFFECT | EFFECT (declared effective) | Lucid Diagnostics Inc. | 9999999995-22-003480 ↗ |
| 2023-06-01 | EFFECT | EFFECT (declared effective) | Lucid Diagnostics Inc. | 9999999995-23-001609 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-08 | S-1/A | registration statement | $1.42 | - | - | 0 | primary document; price line | document ↗ | ||
| 2021-10-15 | 424B4 | final prospectus | $14.00 | 5,000,000 | $70,000,000 | Nasdaq LUCD | 5 | primary document; price sentence, shares headline, proceeds table, cover names 5 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Aklog Lishan | Director,Officer | Chief Executive Officer | 6 | 2021–2026 | |
| Angagaw Aster | Director | 2 | 2021–2022 | ||
| Cox James L | Director | 6 | 2021–2026 | ||
| Lapidus Stanley | Director | 10 | 2021–2026 | ||
| MCGRATH DENNIS M | Officer | Chief Financial Officer | 6 | 2021–2026 | person page Fuzzy |
| PAVmed Inc. | TenPercentOwner | 6 | 2021–2024 | ||
| SOKOLOV JACQUE J | Director | 6 | 2021–2026 | ||
| Sparks Ronald M | Director | 7 | 2021–2026 | ||
| Wurtman David F | Officer | Chief Medical Officer | 1 | 2021 | |
| Gordon Michael Adam | Officer | General Counsel; General Counsel and Secretary | 5 | 2022–2026 | |
| White Debra | Director | 6 | 2022–2026 | ||
| O'Neil Shaun | Officer | Chief Operating Officer; President and COO | 4 | 2023–2026 | |
| Matheis Dennis | Director | 8 | 2024–2026 | ||
| PALUMBO JOHN R | Director | 3 | 2025–2026 | ||
| Lee Victoria Tou-ho | Officer | Chief Medical Officer | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-12-06 | Lucid Diagnostics Inc. | Biotechnology | $21,950,000 | $21,950,000 | 7 | 1 |
| 2023-11-01 | Lucid Diagnostics Inc. | Biotechnology | $5,000,000 | $5,000,000 | 2 | 1 |
| 2023-04-05 | Lucid Diagnostics Inc. | Biotechnology | $11,111,110 | $11,111,110 | 1 | 1 |
| 2023-03-22 | Lucid Diagnostics Inc. | Biotechnology | $20,000,000 | $13,625,000 | 4 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Lucid Diagnostics Inc | NY | State business registries | name and state |
| Business registration | Lucid Diagnostics Inc. | NY | State business registries | name and state |
| Business registration | LUCID DIAGNOSTICS INC. | NY | State business registries | name and state |
| Business registration | LUCID DIAGNOSTICS INC. | NY | State business registries | EIN (EXACT, as the state registration reports it) |
| Form D issuer | Lucid Diagnostics Inc. | NY | Form D private offerings | CIK (EXACT) |
| IPO registrant | PAVmed Inc. | NY | IPO registrations (S-1, F-1) | same street address and ZIP code, 360 MADISON AVE 25TH FL 10017 (FUZZY: a shared address, not proof of a shared organization) |
| Paying company | Lucid Diagnostics Inc. | NY | Open Payments (drug and device company payments) | name and state |
| SEC filer | Lucid Diagnostics Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Lucid Diagnostics Inc. | NY | Trademarks (USPTO) | name and state |
| Person page | Dennis M Mcgrath | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, NY first:
- SWISSRAY INTERNATIONAL INC NY
- BIOPHAN TECHNOLOGIES INC NY
- ANGIODYNAMICS INC NY
- DarioHealth Corp. NY
- iNeedMD Holdings, Inc. NY
- Nemaura Medical Inc. NY
- PAVmed Inc. NY
- Beyond Air, Inc. NY
- OMNIA WELLNESS INC. NY
- INTELLIGENT BIO SOLUTIONS INC. NY
In other datasets, the same topic (Technology) in NY:
- Lobbying client: 1ST ROCHDALE COOPERATIVE GROUP LTD (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology